Influenza virus antigenic variation, host antibody production and new approach to control epidemics

Influenza virus antigenic variation, host antibody production and new approach to control epidemics

Item
http://www.wikidata.org/entity/Q21245119
Q27498375
sameAs
Monoclonal antibody-based therapies for microbial diseasesCompounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part I: Influenza life-cycle and currently available drugsImmunogenicity and safety of an inactivated 2012/2013 trivalent influenza vaccine produced in mammalian cell culture (Optaflu®): an open label, uncontrolled study.Identification and characterisation of a novel anti-viral peptide against avian influenza virus H9N2.The impact of matching vaccine strains and post-SARS public health efforts on reducing influenza-associated mortality among the elderly.Pharmacologic inhibition of COX-1 and COX-2 in influenza A viral infection in mice.Antiangiogenesis immunotherapy induces epitope spreading to Her-2/neu resulting in breast tumor immunoeditingIn Silico Identification of Highly Conserved Epitopes of Influenza A H1N1, H2N2, H3N2, and H5N1 with Diagnostic and Vaccination PotentialA 2013/2014 northern hemisphere season surface antigen inactivated trivalent influenza vaccine--Assessing the immunogenicity and safety in an open label, uncontrolled study.MHC class I-presented T cell epitopes identified by immunoproteomics analysis are targets for a cross reactive influenza-specific T cell responseRole of T-cell epitope-based vaccine in prophylactic and therapeutic applications.Cellular microRNA let-7c inhibits M1 protein expression of the H1N1 influenza A virus in infected human lung epithelial cells.Towards the knowledge-based design of universal influenza epitope ensemble vaccines.Modeling the association of space, time, and host species with variation of the HA, NA, and NS genes of H5N1 highly pathogenic avian influenza viruses isolated from birds in Romania in 2005-2007Immunity toward H1N1 influenza hemagglutinin of historical and contemporary strains suggests protection and vaccine failure.Safety and immunogenicity of the novel seasonal preservative- and adjuvant-free influenza vaccine: blind, randomized and placebo-controlled trial.The bulky and the sweet: How neutralizing antibodies and glycan receptors compete for virus binding.
P2860

Influenza virus antigenic variation, host antibody production and new approach to control epidemics

Item
http://www.wikidata.org/entity/Q21245119
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Influenza virus antigenic vari ...... approach to control epidemics
@ast
Influenza virus antigenic vari ...... approach to control epidemics
@en
Influenza virus antigenic vari ...... approach to control epidemics
@en-gb
Influenza virus antigenic vari ...... approach to control epidemics
@nl
type
label
Influenza virus antigenic vari ...... approach to control epidemics
@ast
Influenza virus antigenic vari ...... approach to control epidemics
@en
Influenza virus antigenic vari ...... approach to control epidemics
@en-gb
Influenza virus antigenic vari ...... approach to control epidemics
@nl
prefLabel
Influenza virus antigenic vari ...... approach to control epidemics
@ast
Influenza virus antigenic vari ...... approach to control epidemics
@en
Influenza virus antigenic vari ...... approach to control epidemics
@en-gb
Influenza virus antigenic vari ...... approach to control epidemics
@nl
P1433
P1476
P2093
P275
P2860
P2888
P304
P31
P3181
P356
P407
P433
P478
P50
P5008
P577
P6179
P698
P921
P932
P3181
P356
P1433
P1476
Influenza virus antigenic vari ...... approach to control epidemics
@en
P2093
P275
P2860
P2888
P304
P31
P3181
P356
P407
P433
P478
P50
P5008
P577
P6179
P698
P921
P932